Invesco’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.36M Buy
251,576
+80,401
+47% +$754K ﹤0.01% 2513
2025
Q1
$1.22M Buy
171,175
+74,741
+78% +$531K ﹤0.01% 2737
2024
Q4
$1.12M Buy
96,434
+3,677
+4% +$42.9K ﹤0.01% 2862
2024
Q3
$1.91M Sell
92,757
-3,273
-3% -$67.3K ﹤0.01% 2615
2024
Q2
$2.15M Sell
96,030
-665
-0.7% -$14.9K ﹤0.01% 2548
2024
Q1
$2.66M Buy
96,695
+24,051
+33% +$662K ﹤0.01% 2536
2023
Q4
$2.21M Buy
72,644
+6,742
+10% +$206K ﹤0.01% 2571
2023
Q3
$2.08M Buy
65,902
+40
+0.1% +$1.27K ﹤0.01% 2572
2023
Q2
$2.69M Sell
65,862
-6,658
-9% -$272K ﹤0.01% 2532
2023
Q1
$2.7M Sell
72,520
-345,358
-83% -$12.9M ﹤0.01% 2510
2022
Q4
$14.6M Buy
417,878
+13,299
+3% +$464K ﹤0.01% 1560
2022
Q3
$22.6M Buy
404,579
+8,239
+2% +$461K 0.01% 1245
2022
Q2
$20.5M Buy
396,340
+7,659
+2% +$396K 0.01% 1357
2022
Q1
$28.2M Sell
388,681
-88,724
-19% -$6.45M 0.01% 1279
2021
Q4
$56.4M Sell
477,405
-193,791
-29% -$22.9M 0.01% 995
2021
Q3
$90M Sell
671,196
-13,435
-2% -$1.8M 0.02% 842
2021
Q2
$111M Sell
684,631
-546,933
-44% -$88.6M 0.03% 789
2021
Q1
$98.8M Sell
1,231,564
-259,385
-17% -$20.8M 0.03% 811
2020
Q4
$81.1M Buy
1,490,949
+1,174,248
+371% +$63.9M 0.02% 823
2020
Q3
$6.3M Buy
316,701
+269,294
+568% +$5.35M ﹤0.01% 1890
2020
Q2
$996K Buy
47,407
+27,485
+138% +$577K ﹤0.01% 2790
2020
Q1
$244K Buy
19,922
+2,034
+11% +$24.9K ﹤0.01% 3308
2019
Q4
$262K Sell
17,888
-1,175
-6% -$17.2K ﹤0.01% 3416
2019
Q3
$254K Sell
19,063
-744
-4% -$9.91K ﹤0.01% 3433
2019
Q2
$324K Sell
19,807
-675
-3% -$11K ﹤0.01% 3435
2019
Q1
$350K Buy
+20,482
New +$350K ﹤0.01% 3416
2018
Q2
Sell
-268,551
Closed -$5.66M 3867
2018
Q1
$5.66M Buy
+268,551
New +$5.66M ﹤0.01% 1881
2016
Q4
Sell
-82,974
Closed -$1.41M 3669
2016
Q3
$1.41M Sell
82,974
-20
-0% -$340 ﹤0.01% 2770
2016
Q2
$1.77M Buy
+82,994
New +$1.77M ﹤0.01% 2546